|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 45, 2252-2259, December 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Department of Veterans Affairs, and Department of Internal Medicine, University of Iowa, Iowa City, IA 52242
1 To whom correspondence should be addressed. e-mail: f-jeffrey-field{at}uiowa.edu
Possible mechanisms for the cholesterol-lowering effects of plant stanol esters were addressed by feeding hamsters diets containing stanol esters, cholesterol, or cholestyramine/lovastatin. ABCA1, ATP binding cassette G1 (ABCG1), ABCG5, ABCG8, and Niemann-Pick C1-like 1 (NPC1L1) mRNA levels were then estimated in duodenum, jejunum, and ileum. Plasma cholesterol was decreased by 36% and 94% in animals fed stanol esters and cholestyramine/lovastatin, respectively. Cholesterol feeding increased plasma cholesterol by 2.5-fold. Plasma plant sterols were unchanged by stanol ester feeding but became undetectable by feeding cholestyramine/lovastatin. Cholesterol and stanols accumulated in enterocytes of animals fed cholesterol and stanol esters, respectively. ABCG5 and ABCG8 mRNA levels were decreased by stanol esters and cholestyramine/lovastatin. Cholesterol feeding markedly increased ABCA1 and ABCG1 expression and modestly increased ABCG5/ABCG8. NPC1L1 mRNA was not significantly altered by any of the diets. ABCG1, ABCG5, ABCG8, and NPC1L1 mRNAs were highest in cells of the upper villus, whereas ABCA1 mRNA was highest in cells of the lower villus.
The results suggest that cholesterol lowering effect of stanol esters is unrelated to changes in mRNA levels of intestinal ABC sterol transporters or NPC1L1. Cholesterol flux regulates ABC expression but not NPC1L1. The different localization of ABCA1 suggests a different function for this protein than for ABCG1, ABCG5, ABCG8, and NPC1L1.
Supplementary key words ATP binding cassette G5 ATP binding cassette G8 ATP binding cassette transporter A1 ATP binding cassette G1 Niemann-Pick C1-like 1 intestine
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. A. Valasek, J. J. Repa, G. Quan, J. M. Dietschy, and S. D. Turley Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G813 - G822. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Field, K. Watt, and S. N. Mathur Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells J. Lipid Res., August 1, 2007; 48(8): 1735 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Huff, R. L. Pollex, and R. A. Hegele NPC1L1: Evolution From Pharmacological Target to Physiological Sterol Transporter Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2433 - 2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jakulj, M. D. Trip, T. Sudhop, K. von Bergmann, J. J. P. Kastelein, and M. N. Vissers Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels J. Lipid Res., December 1, 2005; 46(12): 2692 - 2698. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |